San Diego, CA, United States of America

Jeffrey W Smith

USPTO Granted Patents = 12 

Average Co-Inventor Count = 3.2

ph-index = 6

Forward Citations = 159(Granted Patents)


Location History:

  • Milford, CT (US) (2003)
  • San Diego, CA (US) (1999 - 2012)
  • La Jolla, CA (US) (2010 - 2013)

Company Filing History:


Years Active: 1999-2013

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Jeffrey W. Smith

Introduction

Jeffrey W. Smith, an accomplished inventor based in San Diego, California, has made significant contributions to the field of biomedical research through his innovative patents. With a total of 12 patents to his name, his work focuses on critical advancements in the detection and treatment of colorectal cancer, among other areas.

Latest Patents

One of his most notable recent patents is centered around compositions and methods for the detection of colorectal cancer. This innovative research identified a new variant of ileal bile acid binding protein (IBABP), known as IBABP-L, which serves as a biomarker for colorectal cancer. The discovery highlights that the transcript for IBABP-L originates from an alternative start site, comprising three exons that are not present in the original IBABP. The protein encoded by IBABP-L reveals a unique 49 residue N-terminal sequence exclusive to this variant, enhancing the methods available for diagnosing colorectal cancer.

Another significant patent involves the development of beta-lactone compounds. This invention provides compounds characterized by a specific general structure, where the alkyl group can include various functional moieties such as alkyl, alkenyl, aryl, heterocycles, hydroxyl, ester, amido, aldehyde, and halogen. These compounds have potential applications in pharmaceuticals, expanding the options available in medicinal chemistry.

Career Highlights

Jeffrey W. Smith has held positions in reputed institutions, notably the Burnham Institute for Medical Research. His pioneering work has positioned him as a leader in the development of diagnostic tools and therapeutic compounds, contributing to advancements that have broader implications in healthcare.

Collaborations

Throughout his career, Smith has collaborated with notable scientists including Steven J. Kridel and Daniel Romo. These collaborations have enhanced his research and development processes, fostering an environment of innovation and shared expertise in the scientific community.

Conclusion

Jeffrey W. Smith's innovative efforts in the realm of biomedical research underscore his importance as an inventor dedicated to improving health outcomes. His developments in cancer detection and pharmaceutical compounds continue to pave the way for future advancements, illustrating the significant impact of his work in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…